- Home
- TSHA vs GLDD Comparison
TSHA vs GLDD Comparison
Compare TSHA & GLDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TSHA | GLDD |
|---|---|---|
| Founded | 2019 | 1890 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2020 | 2007 |
Fundamental Metrics
Financial Performance| Metric | TSHA | GLDD |
|---|---|---|
| Price | $4.52 | $16.95 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 1 |
| Target Price | $10.56 | ★ $17.00 |
| AVG Volume (30 Days) | 2.1M | ★ 2.3M |
| Earning Date | 01-01-0001 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.50 | 28.57 |
| EPS | N/A | ★ 1.08 |
| Revenue | $8,333,000.00 | ★ $702,503,000.00 |
| Revenue This Year | N/A | $3.79 |
| Revenue Next Year | N/A | $9.01 |
| P/E Ratio | ★ N/A | $15.68 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.13 | $7.51 |
| 52 Week High | $6.02 | $16.99 |
Technical Indicators
Market Signals| Indicator | TSHA | GLDD |
|---|---|---|
| Relative Strength Index (RSI) | 42.92 | 68.25 |
| Support Level | $4.41 | $14.60 |
| Resistance Level | $5.16 | $16.99 |
| Average True Range (ATR) | 0.20 | 0.05 |
| MACD | -0.00 | -0.10 |
| Stochastic Oscillator | 20.13 | 68.18 |
Price Performance
Historical ComparisonAbout TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About GLDD Great Lakes Dredge & Dock Corporation
Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.